Prestige Consumer Healthcare (PBH) Stock
Owner and marketer of branded healthcare and household products. Here's the price, business snapshot, and what's worth knowing about Prestige Consumer Healthcare in July 2026.
Prestige Brands Holdings, Inc. (PBH) is a US‑based owner and marketer of branded over‑the‑counter healthcare, household and personal‑care products. With a market capitalisation of about $3.08 billion, the company grows by supporting established consumer brands across pharmacy, grocery and online channels, combining marketing, distribution and selective acquisitions. Investors should note the business is cash‑generative but historically operates with meaningful leverage from past buy‑and‑build activity, which can make earnings sensitive to interest rates and refinancing cycles. Key potential positives include steady demand for staple healthcare items, brand pricing power and opportunities in e‑commerce and international expansion. Key risks include competition, changing retailer dynamics, input‑cost inflation and the possibility that acquisitions fail to meet expectations. This summary is educational and not personalised investment advice; stock values can rise or fall and past performance is not a guide to the future. Consider your risk tolerance and time horizon before deciding whether this stock fits your portfolio.
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying Prestige Consumer Healthcare's stock, predicting a significant price increase.
Financial Health
Prestige Consumer Healthcare is generating solid revenue and cash flow, indicating a healthy business operation.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
AbbVie
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
ASTRAZENECA PLC
AstraZeneca is a global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative medicines.
AMGEN INC
Amgen is a global biotechnology company that focuses on discovering, developing and commercializing treatments for unmet medical needs.
Baskets Featuring PBH
Premium Beauty Stocks | Risks and Resilient Demand
Ulta Beauty's strong first-quarter earnings and raised profit forecast highlight the enduring consumer demand for high-end cosmetics and personal care. This basket tracks premium beauty brands and specialized retailers poised to benefit from resilient spending on affordable luxuries.
Published: 3 June 2026
Explore BasketDefensive Equities | Risks in a Slowing Labour Market
After the U.S. economy unexpectedly shed 92,000 jobs in February, investors are seeking shelter from the resulting market volatility. This collection features resilient, non-cyclical companies that historically maintain their value and offer stability during periods of economic deceleration.
Published: 9 March 2026
Explore BasketJ&J Talc Crisis Impact Explained | Health Stocks
A jury verdict found Johnson & Johnson liable in a talc cancer case, one of over 63,000 similar lawsuits the company faces. This ongoing legal crisis may drive consumers toward competitors, creating an investment opportunity in other personal care and consumer health companies.
Published: 15 February 2026
Explore BasketWalgreens Restructuring Explained: Investment Shifts
Following its acquisition by Sycamore Partners, Walgreens has gone private and split into five companies. This theme explores the investment opportunities created by the newly independent healthcare and retail entities.
Published: 2 September 2025
Explore BasketWalgreens' Restructuring: A New Healthcare Landscape
Following its $10 billion acquisition by Sycamore Partners, Walgreens is going private and splitting into five separate companies. This major restructuring of a key industry player could create significant opportunities for competitors and specialized healthcare service providers to capture market share.
Published: 29 August 2025
Explore BasketThe Resilient Premium Consumer
This carefully selected group of stocks focuses on companies catering to affluent consumers who continue spending despite economic uncertainty. Based on American Express's record revenue from premium cardholders, these professional-picked investments target the luxury segment's enduring strength.
Published: 21 July 2025
Explore BasketSmart Shopper Portfolio
Invest in brands you already know and trust that stock your shelves at home. These aren't just familiar names—they're companies that financial experts have given their strongest vote of confidence with "Strong Buy" ratings.
Published: 17 June 2025
Explore BasketWhy You’ll Want to Watch This Stock
Steady brand demand
Established OTC and household brands often sustain consistent sales; however, performance can vary with retail trends and competition.
Acquisition strategy focus
Management has used acquisitions to add scale and new products, which can boost growth but may raise leverage and execution risk.
Retail and e‑commerce mix
Sales rely on pharmacies, supermarkets and online channels, offering diversification yet exposing the business to changing retailer dynamics.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
